Abstract
Several examples from Germany indicate that the provision of opioid agonist treatment (OAT) to people living in prisons is rather fragementary. As prison healthcare is in the responsability of the Ministries of Justice in the 16 ‘Länder’ (states) the health care for opioid dependent prisoners is rather heterogenous, there are countries with almost no waiting list for patients and there are Länder with hardly any provision of this kind of treatment at all, which means that people who are in treatment will not receive a continuation. The European Committee for the Prevention of Torture (CPT) clearly stated that such a state of affairs is clearly not in compliance with the principle of equivalence of care. The Court also dealt with such a case and found that the physical and mental strain that the applicant suffered as a result of his untreated or inadequately treated health condition could, in principle, amount to inhuman or degrading treatment. The Court concluded that the failure to adequately assess the applicants’s treatment needs involves a violation of the prohibition of inhuman or degrading treatment (article 3 of the European Convention of Human Rights). This article is addressing the health inequality in prisons in the German federal states. The supply of OAT inclusive psychosocial support in prison is still inadequate and falls short of the therapy standard for people outside of prison. There is still a gap between the number of people living in prison in need of opioid agonist treatment and those receiving it, although benefits such as reduced risk of death in the post-release period, reduced risk of transmission of infectious diseases, and reduced reoffending have been shown.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
ECtHR, Wenner v. Germany, Application No. 62303/13, Judgment of 01 September 2016.
- 2.
CPT (2017), Report to the German Government on the visit to Germany carried out by the European Committee for the Prevention of Torture and Inhuman or Degrading Treatment, CPT/Inf (2017) 13, para 61.
- 3.
Ibid.
- 4.
Ministry of Justice and for Europe (2018).
- 5.
The United Nations Office on Drugs and Crime UNODC (2015), Standard Minimum Rules for the Treatment of Prisoners (the Nelson Mandela Rules).
- 6.
- 7.
Nosrati et al. (2019).
- 8.
Kastelic et al. (2007).
- 9.
Stallwitz and Stöver (2007), pp. 464–474.
- 10.
International Covenant on Economic, Social and Cultural Rights, adopted by UNGA Res. 2200A (XXI) of 16 December 1966, entered into force 3 January 1976.
- 11.
Pont (2008), pp.184–197.
- 12.
- 13.
Deutsche AIDS-Hilfe (2018), Substitution in Haft. Deine Rechte, deine Möglichkeiten.
- 14.
- 15.
- 16.
Hedrich et al. (2012), pp. 501–517.
- 17.
Bundesministerium für Justiz und Verbraucherschutz (2001), Betäubungsmittel-Verschreibungsverordnung - BtMVV. vol. § 5 paragraph 2 sentence 1.
- 18.
Wakeman (2017), pp. 922–930.
- 19.
Opitz-Welke et al. (2018), pp. 808–814.
- 20.
- 21.
Zurhold et al. (2005).
- 22.
Anderson and Kearney (2000), pp. 43–46.
- 23.
- 24.
United Nations Office on Drugs and Crime, International Labour Organization, UNDP, World Health Organization, UNAIDS (2013), HIV prevention, treatment and care in prisons and other closed settings: a comprehensive package of interventions.
- 25.
Institute for Crime & Justice Policy Research (ICPR), Birkbeck University of London (2018) World Prison Data.
- 26.
Pont et al. (2012).
- 27.
Reimer et al. (2009), pp. A-2227.
- 28.
Deutsche AIDS-Hilfe (2018), Substitution in Haft. Deine Rechte, deine Möglichkeiten.
- 29.
Junod et al. (2018), pp. 31–36.
- 30.
Lampert et al. (2016), pp. 153–165.
- 31.
Lampert et al. (2017).
- 32.
Fazel and Baillargeon (2011), pp. 956–65.
- 33.
Lampert et al. (2018).
- 34.
BMG—Bundesministerium für Gesundheit (2015), Gesetz zur Stärkung der Gesundheitsförderung und Prävention (Präventionsgesetz – PrävG)
- 35.
- 36.
- 37.
Keppler and Stöver (2009); Senatsverwaltung für Justiz, Verbraucherschutz und Antidiskriminierung, Abraham (2017), Uniform federal data collection on substance-bound addiction problems in the prison system [Presentation in German], In 9th European Conference on Health Promotion in Detention, Land Berlin, Vienna 22 Sep.
- 38.
Oberlandesgericht München (2012), Urteil vom 05.06.2012 - 4 Ws 103/12 (R), Jurisdiction, München.
- 39.
Deutscher Bundestag (2016), State of affairs WD 9 - 3000 - 049/16, Substitutionsbehandlung im Justizvollzug, pp. 7–8.
- 40.
Die Drogenbeauftragte der Bundesregierung (2019), Drogen- und Suchtbericht 2019, Druck- und Verlagshaus Zarbock GmbH & Co. KG, Frankfurt.
- 41.
- 42.
Deutscher Bundestag (2016), pp. 7–8.
- 43.
Ibid.
- 44.
- 45.
Deutscher Bundestag (2016), pp. 7–8.
- 46.
Ibid.
- 47.
Ibid. footnote 46.
- 48.
Schäffler and Zimmermann (2012).
- 49.
- 50.
- 51.
Ibid.
- 52.
Deutsche AIDS-Hilfe (2018), Substitution in Haft. Deine Rechte, deine Möglichkeiten.
- 53.
Bundesärztekammer (2017), Richtlinie der Bundesärztekammer zur Durchführung der substitutionsgestützten Behandlung Opiodabhängiger.
- 54.
Kastelic et al. (2009).
- 55.
Friedmann and Schwartz (2012), p. 10.
- 56.
Global commission on drug policy (2017), The World Drug Perception Problem – Report.
- 57.
Nunn et al. (2009), pp. 83–88.
- 58.
Friedmann et al. (2012), pp. 9–18.
- 59.
Volkow et al. (2014), pp. 2063–2066.
- 60.
Goodman (2013), pp. 81–82.
- 61.
Tretter et al. (2010), p. 2.
- 62.
Ibid.; Wiese (2012).
- 63.
Deutsche AIDS-Hilfe (2018), Substitution in Haft. Deine Rechte, deine Möglichkeiten.
- 64.
Fährmann et al. (2021a).
- 65.
Sordo et al. (2017), p. j1550.
- 66.
Marsden et al. (2017), pp. 1408–1418.
- 67.
- 68.
Kinlock et al. (2007), pp. 220–227.
- 69.
Pont et al. (2012).
- 70.
Fazel and Baillargeon (2011), pp. 956–965.
- 71.
Altice et al. (2016), pp. 1228–1248.
- 72.
Haussig (2018), pp. 5–13.
- 73.
Fazel and Baillargeon (2011), pp. 956–965.
- 74.
Gaube et al. (1993), pp. 246–249.
- 75.
Zylka-Menhorn (1999), pp. 312ff.
- 76.
Müller et al. (2017), p. 843.
- 77.
Deutsche AIDS-Hilfe (2018), Substitution in Haft. Deine Rechte, deine Möglichkeiten.
- 78.
Csete and Catania (2013), p. 10:35.
- 79.
Wakeman (2017), pp. 922–930
- 80.
U.S. National Library of Medicine (2018), Opioid addiction. Genetics Home Reference; Poehlke et al.(2016); United Nations Office on Drugs and Crime (2017), Prevention of drug use and treatment of drug use disorders in rural settings. Revised Version, Special Population Series. United Nations, New York.
- 81.
Fährmann et al. (2021b).
- 82.
Fährmann et al. (2021b).
- 83.
von Bernuth et al. (2020).
- 84.
Ibid., p. 2.
References
Altice FL, Azbel L, Stone J, Brooks-Pollock E, Smyrnov P, Dvoriak S, Taxman FS, El-Bassel N, Martin NK, Booth R et al (2016) The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia. The Lancet 388:1228–1248
Anderson IB, Kearney TE (2000) Use of methadone. West J Med 172:43–46
Arcaya MC, Arcaya AL, Subramanian SV (2015) Inequalities in health: definitions, concepts, and theories. Global Health Action 8:27106–27106
Bart G (2012) Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis 31:207–225
BMG – Bundesministerium für Gesundheit (2015) Gesetz zur Stärkung der Gesundheitsförderung und Prävention (Präventionsgesetz – PrävG). http://www.bgbl.de/xaver/bgbl/start.xav?startbk=BundesanzeigerBGBl&jumpTo=bgbl115s1368.pdf
Bundesärztekammer (2017) Richtlinie der Bundesärztekammer zur Durchführung der substitutionsgestützten Behandlung Opiodabhängiger. https://www.bundesaerztekammer.de/richtlinien/richtlinien/substitutionstherapie/
Bundesgesundheitsministerium (2018) Schätzungen Opiodabhängiger in Deutschland. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwik_pXNiJrxAhUHgP0HHU7WDMsQFjAAegQIAxAD&url=https%3A%2F%2Fwww.bundesgesundheitsministerium.de%2Ffileadmin%2FDateien%2F5_Publikationen%2FDrogen_und_Sucht%2FBerichte%2FAbschlussberichtOpiS-Bericht_150518.pdf&usg=AOvVaw0QzCUhAihzWN76_6HoG-V5
Bundesinstitut für Arzneimittel und Medizinprodukte (2018) Bericht zum Substitutionsregister. Bundesopiumstelle, Bonn, p 4
Bundesministerium für Justiz und Verbraucherschutz (2001) Betäubungsmittel-Verschreibungsverordnung - BtMVV. vol. § 5 paragraph 2 sentence 1. https://www.gesetze-im-internet.de/btmvv_1998/__5.html
Csete J, Catania H (2013) Methadone treatment providers’ views of drug court policy and practice: a case study of New York State. Harm Reduct J 10:35
Deimel D (2014) Psychosoziale Behandlung in der Substitutionstherapie: Praxis Klinischer Sozialarbeit. Tectum Verlag, Marburg
Deutsche AIDS-Hilfe (2018) Substitution in Haft. Deine Rechte, deine Möglichkeiten. https://www.aidshilfe.de/system/files_force/documents/2018_02_13_substitution_in_haft.pdf?download=1
Deutscher Bundestag (2016) State of affairs WD 9 - 3000 - 049/16. Substitutionsbehandlung im Justizvollzug. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&cad=rja&uact=8&ved=2ahUKEwiomdqggJrxAhXF5KQKHQZtB9IQFjAAegQIAxAD&url=https%3A%2F%2Fwww.bundestag.de%2Fblob%2F480528%2F079376bd958e4a1b9baa2652713d63cb%2Fwd-9-049-16-pdf-data.pdf&usg=AOvVaw3ujEPyTks1ZgPF7JKBKoQF, pp 7–8
Die Drogenbeauftragte der Bundesregierung (2019) Drogen- und Suchtbericht 2019. Druck- und Verlagshaus Zarbock GmbH&Co. KG, Frankfurt
Dole VP (1972) Detoxification of sick addicts in prison. Jama 220:366–369
Dole VP, Nyswander ME (1966) Rehabilitation of heroin addicts after blockade with methadone. N Y State J Med 66:2011–2017
European Court of Human Rights (2016) Case of Wenner v Germany (Application no. 62303/13). https://hudoc.echr.coe.int/fre#{%22itemid%22:[%22001-165758%22]}.
Fährmann J, Schuster S, Stöver H, Häßler U, Keppler K (2021a) Der Anspruch auf Substitutionsbehandlung im Gefängnis. Über eine umstrittene Praxis im Justizvollzug und vor Gericht. NStZ. Beck, München
Fährmann J, Lesting J, Stöver H, Häßler U, Schuster S, Keppler K (2021b) Die Substitutionsbehandlung – vollzugliche Veränderungsresistenz als Gefahr für Grund- und Menschenrechte der Gefangenen. Vorgänge. Humanistische Union, Berlin
Fazel S, Baillargeon J (2011) The health of prisoners. Lancet 377:956–965
Fazel S, Bains P, Doll H (2006) Substance abuse and dependence in prisoners: a systematic review. Addiction 101:181–191
Friedmann PD, Schwartz RP (2012) Just call it “treatment”. Addict Sci Clin Pract 7:10–10
Friedmann PD, Hoskinson R, Gordon M, Schwartz R, Kinlock T, Knight K, Flynn PM, Welsh WN, Stein LA, Sacks S et al (2012) Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions. Subst Abus 33:9–18
Gaube J, Feucht HH, Laufs R, Polywka S, Fingscheidt E, Muller HE (1993) Hepatitis A, B und C als desmoterische Infektionen. Gesundheitswesen 55:246–249
Global Commission on Drug Policy (2017) The World Drug Perception Problem – Report. http://www.globalcommissionondrugs.org/wp-content/uploads/2018/01/GCDP-Report-2017_Perceptions-ENGLISH.pdf
Goodman B (2013) Erving Goffman and the total institution. Nurse Educ Today 33:81–82
Groß G (2021) Entwicklung der Substitutionsbehandlung im bayerischen Strafvollzug am Beispiel der Justizvollzugsanstalt Straubing. Suchtmedizin 23(2):74–80
Gross G, Conroy S, Leonardi C, Meroueh F, Antolin J, Somaini L (2021) Reducing opioid dependence therapy risk in the prison system and the use of extended-release buprenorphine as an additional treatment option: a consensus statement. Heroin Addict Relat Clin Probl
Haussig JM, Nielsen S, Gassowski M, Bremer V, Marcus U, Wenz B, Bannert N, Bock CT, Zimmermann R (2018) A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities. Int J Infect Dis 66:5–13
Hedrich D, Alves P, Farrell M, Stover H, Moller L, Mayet S (2012) The effectiveness of opioid maintenance treatment in prison settings: a systematic review. Addiction 107:501–517
Institute for Crime & Justice Policy Research (ICPR), Birkbeck University of London (2018) World Prison Data. http://www.prisonstudies.org/country/germany
Junod V, Wolff H, Scholten W, Novet B, Greifinger R, Dickson C, Simon O (2018) Methadone versus torture: the perspective of the European Court of Human Rights. Heroin Addict Relat Clin Probl 20:31–36
Kastelic A, Pont J, Stöver H (2007) Substitution treatment in European prisons - a practical guide. ENDIPP, Bonn
Kastelic A, Stöver H, Pont J (2009) Opioid substitution treatment in custodial settings. BIS Verlag, Oldenburg
Keppler K, Stöver H (2009) Gefängnismedizin. Medizinische Versorgung unter Haftbedingungen. Thieme, Stuttgart/New York
Kinlock TW, Gordon MS, Schwartz RP, O'Grady K, Fitzgerald TT, Wilson M (2007) A randomized clinical trial of methadone maintenance for prisoners: results at 1-month pOAT-release. Drug Alcohol Depend 91:220–227
Lampert T, Richter M, Schneider S, Spallek J, Dragano N (2016) Soziale Ungleichheit und Gesundheit. Stand und Perspektiven der sozialepidemiologischen Forschung in Deutschland. Bundesgesundheitsbl 59:153–165
Lampert T, Hoebel J, Kuntz B, Müters S, Kroll LE (2017) Gesundheitliche Ungleichheit in verschiedenen Lebensphasen https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwi3r5LzppfxAhUjzYUKHUSsC0wQFjABegQIBBAD&url=https%3A%2F%2Fwww.rki.de%2FDE%2FContent%2FGesundheitsmonitoring%2FGesundheitsberichterstattung%2FGBEDownloadsB%2Fgesundheitliche_ungleichheit_lebensphasen.pdf%3F__blob%3DpublicationFile&usg=AOvVaw0_iKhX7Vp6P_kI5mqWZB-L
Lampert T, Kroll LE, Kuntz B, Hoebel J (2018) Gesundheitliche Ungleichheit in Deutschland und im internationalen Vergleich: Zeitliche Entwicklungen und Trends. Journal of Health Monitorin 3(S1). Robert Koch Institut, Berlin
Marsden J, Stillwell G, Jones H, Cooper A, Eastwood B, Farrell M, Lowden T (2017) Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. Addiction 112:1408–1418
Ministry of Justice and for Europe (2018) Bundeseinheitliche Erhebung zur stoffgebundenen Suchtproblematik im Justizvollzug. https://www.landtag-bw.de/files/live/sites/LTBW/files/dokumente/WP16/Drucksachen/5000/16_5382_D.pdf
Mortler M (2018) Drogen- und Suchtbericht 2018. Die Drogenbeauftragte der Bunderesgierung, Berlin
Müller J, Schmidt D, Kollan C, Lehmann M, Bremer V, Zimmermann R (2017) High variability of TB, HIV, hepatitis C treatment and opioid substitution therapy among prisoners in Germany. BMC Public Health 17:843
Nosrati E, Kang-Brown J, Ash M, McKee M, Marmot M, Kin LP (2019) Economic decline, incarceration, and mortality from drug use disorders in the USA between 1983 and 2014: an observational analysis. Lancet Public Health 4:e326–e333. https://www.thelancet.com/action/showPdf?pii=S2468-2667%2819%2930104-5
Nunn A, Zaller N, Dickman S, Trimbur C, Nijhawan A, Rich JD (2009) Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend 105:83–88
Oberlandesgericht München (2012) Urteil vom 05.06.2012 - 4 Ws 103/12 (R). Jurisdiction, München
Opitz-Welke A, Lehmann M, Seidel P, Konrad N (2018) Medicine in the penal system. Deutsches Ärzteblatt 115:808–814
Poehlke T, Heinz W, Stöver H (2016) Drogenabhängigkeit und Substitution - ein Glossar von A–Z. Springer Verlag, Münster/Frankfurt
Pont J, Kastelic A, Stöver H, Ritter C, Knorr B (2012) Substitutionsbehandlung im Strafvollzug: ein praktischer Leitfaden. Dt. Aidshilfe, Berlin
Reimer J, Schulte B, Stöver H (2009) Entschiedenes Handeln notwendig: Suchtmedizinische Versorgung Opiatabhängiger in deutschen Haftanstalten. Dt. Ärzteblatt 106(45):A-2227. https://www.aerzteblatt.de/archiv/66629
Rodley N, Pollard M (2009) The treatment of prisoners under international law, 3rd edn. Oxford University Press, Oxford
Schäffler F, Zimmermann S (2012) Drogenabhängigkeit in bayerischen Haftanstalten. Darstellung und Diskussion ausgewählter Ergebnisse einer bayernweiten Umfrage bei ehemals inhaftierten, drogenabhängigen Menschen. INDRO e.V., Münster
Senatsverwaltung für Justiz, Verbraucherschutz und Antidiskriminierung, Abraham K (2017) Uniform federal data collection on substance-bound addiction problems in the prison system [Presentation in German]. In 9th European Conference on Health Promotion in Detention, Land Berlin, Vienna 22 Sep
Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R (2017) Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ 357:j1550
Stöver H, Keppler K Opioidsubstitutionsbehandlung im Justizvollzug (2021) Welche Belege für die Wirksamkeit, welche Hindernisse und welche Lösungsmöglichkeiten bestehen? Suchtmedizin 23(2):59-66
The Lancet Editorial Board (2013) Improving prisoner health for stronger public health. The Lancet. 2021 Feb 13;397(10274):555 https://www.thelancet.com/action/showPdf?pii=S0140-6736%2821%2900361-5
Tretter F, Fahrmbacher-Lutz C, Höffner U, Zeitler D, Bystron C, Schwejda C (2010) Leitfaden für Ärzte zur substitutionsgestützten Behandlung Opiatabhängiger. Bayerische Akademie für Sucht- und Gesundheitsfragen, München, p 2
U.S. National Library of Medicine (2018) Opioid addiction. Genetics Home Reference
United Nations Office on Drugs and Crime (2003) Investing in Drug Abuse Treatment - A Discussion Paper for Policy Makers. United Nations, New York
United Nations Office on Drugs and Crime (2017) Prevention of drug use and treatment of drug use disorders in rural settings. Revised Version, Special Population Series. United Nations, New York
United Nations Office on Drugs and Crime, International Labour Organization, UNDP, World Health Organization, UNAIDS (2013) HIV prevention, treatment and care in prisons and other closed settings: a comprehensive package of interventions. https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiz6YqL1JvxAhXVgP0HHRPhDdkQFjAAegQIAxAD&url=http%3A%2F%2Fwww.unodc.org%2Fdocuments%2Fhiv-aids%2FHIV_comprehensive_package_prison_2013_eBook.pdf&usg=AOvVaw1lIOIy5MDQpBR3IMf2QVNw
United Nations Office on Drugs and Crime UNODC (2015) Standard Minimum Rules for the Treatment of Prisoners (the Nelson Mandela Rules). https://www.unodc.org/documents/justice-and-prison-reform/Nelson_Mandela_Rules-E-ebook.pdf
Volkow ND, Frieden TR, Hyde PS, Cha SS (2014) Medication-assisted therapies--tackling the opioid-overdose epidemic. N Engl J Med 370:2063-2066
von Bernuth K, Seidel P, Krebs J, Lehmann M, Neumann B, Konrad N, Opitz-Welke A (2020) Prevalence of opioid dependence and opioid agonist treatment in the berlin custodial setting: a cross-sectional study. Front Psychiatry 11. https://doi.org/10.3389/fpsyt.2020.00794
Wakeman SE (2017) Why it’s inappropriate not to treat incarcerated patients with opioid agonist therapy. AMA J Ethics 19:922–930
Whitehead M (1992) The concepts and principles of equity and health. Int J Health Serv 22:429–445
Wiese B (2012) Prädiktoren für die vorzeitige Therapiebeendigung von Patienten in opiatgestützter Behandlung. Dissertation, Medizinische Fakultät der Universität München
World Health Organization (2009) WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. WHO, Geneva
Zurhold H, Haasen C, Stöver H (2005) Female drug users in European prisons. A European study of prison policies, prison drug services and the women’s perspectives. BIS-Verlag, Oldenburg
Zylka-Menhorn V (1999) 7. Münchner AIDS-Tage: Mehr HIV- und HCV-Doppelinfektionen. Dtsch Ärztebl International 96:312ff
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Annexes
Annexes
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Stöver, H., Pont, J., Wolff, H., Enggist, S. (2022). Discontinuation of Adequate Opioid Agonist Treatment in Prison: A Violation of Human Rights. In: Burbano Herrera, C., Haeck, Y. (eds) Human Rights Behind Bars. Ius Gentium: Comparative Perspectives on Law and Justice, vol 103. Springer, Cham. https://doi.org/10.1007/978-3-031-11484-7_11
Download citation
DOI: https://doi.org/10.1007/978-3-031-11484-7_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-11483-0
Online ISBN: 978-3-031-11484-7
eBook Packages: Law and CriminologyLaw and Criminology (R0)